Clinical trialNo phase (not a drug trial)Completed
Trial Comparing 19 and 25-gauge EUS-FNA Needles
Multi-Center Randomized Trial Comparing 19 and 25-gauge Needles for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) of Solid Pancreatic Mass Lesions
- Outcome
- Results posted; no analysis attached
- Phase
- No phase (not a drug trial)
- Status
- Completed
- Study type
- Interventional
- Start
- August 2012
- Ended
- January 2013
- Enrollment
- 72 participants
- Sites
- 2
- Primary outcomes
- Median Number of Passes to Establish Diagnosis
- Sponsor type
- Academic / other
- Results posted
- 17 March 2020
- Last update
- 17 March 2020
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Results
- Primary endpoint
- Results posted; no analysis attachedAs posted on ClinicalTrials.gov ↗, registry record of 17 March 2020
- Primary outcome
- Median Number of Passes to Establish Diagnosis19G FNA Needle: 1 (1 to 1), n = 3625G FNA Needle: 1 (1 to 1), n = 36Values: median No. of passes, Inter-Quartile RangeTime frame: 5 monthsNo analysis posted for this outcome (outcome 1)
- Participants
- 19G FNA Needle: 36 started, 36 completed25G FNA Needle: 36 started, 36 completed
- Serious adverse events
- 19G FNA Needle: 0 of 3625G FNA Needle: 0 of 36Participants with at least one serious adverse event, of those at risk, as posted
3 secondary outcomes
- Procurement of Histological Samples
- 19G FNA Needle 86.1, n=36; 25G FNA Needle 33.3, n=36 [percentage of participants]
- Needle Dysfunction
- 19G FNA Needle 0, n=36; 25G FNA Needle 2.8, n=36 [percentage of participants]
- Complications
- 19G FNA Needle 2.8, n=36; 25G FNA Needle 0, n=36 [percentage of participants]
Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This study compares the 19G and 25G needles for procuring tissue samples from the pancreas during Endoscopic Ultrasound (EUS) procedures.
Detailed description public domain (ClinicalTrials.gov)
The study compares the median number of passes to establish a definitive diagnosis using the 19G or 25G needles. Also, the ability of both needles to procure a histological core tissue is assessed.
Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)
Median Number of Passes to Establish Diagnosis [5 months]. Median, No. of passes (Inter-Quartile Range). 19G FNA Needle (n=36): 1 (1 to 1); 25G FNA Needle (n=36): 1 (1 to 1).
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Procurement of Histological Samples [30 days]. Number, percentage of participants. 19G FNA Needle (n=36): 86.1; 25G FNA Needle (n=36): 33.3.
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Needle Dysfunction [2 hours]. Number, percentage of participants. 19G FNA Needle (n=36): 0; 25G FNA Needle (n=36): 2.8.
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
Complications [30 days]. Number, percentage of participants. 19G FNA Needle (n=36): 2.8; 25G FNA Needle (n=36): 0.